ANTI CANCER USE OF CAFFEIC ACID AND DERIVATIVES
The present invention relates to the use of caffeic acid or a derivative thereof represented by the following general formula (1) wherein X is O, NH, or heterocyclyl; R may be present or absent and if present, is H, alkyl, ar yl, or heterocyclyl; in all its stereoisomeric and tautomeric forms, and m...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WAGH, VILAS SAMPATRAO DESHPANDE, AMIT AWARE, VALMIK SOPAN SARDE, ANKUSH GANGARAM SHARMA, SOMESH SIVAKUMAR, MEENAKSHI JOSHI, KALPANA SANJAY |
| description | The present invention relates to the use of caffeic acid or a derivative thereof represented by the following general formula (1) wherein X is O, NH, or heterocyclyl; R may be present or absent and if present, is H, alkyl, ar yl, or heterocyclyl; in all its stereoisomeric and tautomeric forms, and mix tures thereof in all ratios, and a pharmaceutically acceptable salt, pharmac eutically acceptable solvate, pharmaceutically acceptable polymorph, in the treatment of chronic myeloid leukemia (CML) which is resistant to treatment with Gleevec. The invention also relates to the reduction of the proliferati on of cells that are resistant to Gleevec by contacting the cells with a com pound of general formula (1 ). The present invention also relates to pharmac eutical compositions (for the manufacture of the medicament) including caffe ic acid or a derivative or a salt thereof represented by the general formula (1 ) for the treatment of chronic myeloid leukemia (CML) that is resistant to treatment with Gleevec, or for reducing the proliferation of cells that a re resistant to Gleevec. The present invention further relates to the treatm ent of chronic myeloid leukemia (CML) that is resistant to treatment with Gl eevec. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2662126A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2662126A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2662126A13</originalsourceid><addsrcrecordid>eNrjZNB39AvxVHB29HN2DVIIDXZV8HcD8tzcXD2dFRydPV0UHP1cFFxcgzzDHEM8w1yDeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjkZmZkaGRmaOhMRFKAHA4JNM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI CANCER USE OF CAFFEIC ACID AND DERIVATIVES</title><source>esp@cenet</source><creator>WAGH, VILAS SAMPATRAO ; DESHPANDE, AMIT ; AWARE, VALMIK SOPAN ; SARDE, ANKUSH GANGARAM ; SHARMA, SOMESH ; SIVAKUMAR, MEENAKSHI ; JOSHI, KALPANA SANJAY</creator><creatorcontrib>WAGH, VILAS SAMPATRAO ; DESHPANDE, AMIT ; AWARE, VALMIK SOPAN ; SARDE, ANKUSH GANGARAM ; SHARMA, SOMESH ; SIVAKUMAR, MEENAKSHI ; JOSHI, KALPANA SANJAY</creatorcontrib><description>The present invention relates to the use of caffeic acid or a derivative thereof represented by the following general formula (1) wherein X is O, NH, or heterocyclyl; R may be present or absent and if present, is H, alkyl, ar yl, or heterocyclyl; in all its stereoisomeric and tautomeric forms, and mix tures thereof in all ratios, and a pharmaceutically acceptable salt, pharmac eutically acceptable solvate, pharmaceutically acceptable polymorph, in the treatment of chronic myeloid leukemia (CML) which is resistant to treatment with Gleevec. The invention also relates to the reduction of the proliferati on of cells that are resistant to Gleevec by contacting the cells with a com pound of general formula (1 ). The present invention also relates to pharmac eutical compositions (for the manufacture of the medicament) including caffe ic acid or a derivative or a salt thereof represented by the general formula (1 ) for the treatment of chronic myeloid leukemia (CML) that is resistant to treatment with Gleevec, or for reducing the proliferation of cells that a re resistant to Gleevec. The present invention further relates to the treatm ent of chronic myeloid leukemia (CML) that is resistant to treatment with Gl eevec.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080306&DB=EPODOC&CC=CA&NR=2662126A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080306&DB=EPODOC&CC=CA&NR=2662126A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WAGH, VILAS SAMPATRAO</creatorcontrib><creatorcontrib>DESHPANDE, AMIT</creatorcontrib><creatorcontrib>AWARE, VALMIK SOPAN</creatorcontrib><creatorcontrib>SARDE, ANKUSH GANGARAM</creatorcontrib><creatorcontrib>SHARMA, SOMESH</creatorcontrib><creatorcontrib>SIVAKUMAR, MEENAKSHI</creatorcontrib><creatorcontrib>JOSHI, KALPANA SANJAY</creatorcontrib><title>ANTI CANCER USE OF CAFFEIC ACID AND DERIVATIVES</title><description>The present invention relates to the use of caffeic acid or a derivative thereof represented by the following general formula (1) wherein X is O, NH, or heterocyclyl; R may be present or absent and if present, is H, alkyl, ar yl, or heterocyclyl; in all its stereoisomeric and tautomeric forms, and mix tures thereof in all ratios, and a pharmaceutically acceptable salt, pharmac eutically acceptable solvate, pharmaceutically acceptable polymorph, in the treatment of chronic myeloid leukemia (CML) which is resistant to treatment with Gleevec. The invention also relates to the reduction of the proliferati on of cells that are resistant to Gleevec by contacting the cells with a com pound of general formula (1 ). The present invention also relates to pharmac eutical compositions (for the manufacture of the medicament) including caffe ic acid or a derivative or a salt thereof represented by the general formula (1 ) for the treatment of chronic myeloid leukemia (CML) that is resistant to treatment with Gleevec, or for reducing the proliferation of cells that a re resistant to Gleevec. The present invention further relates to the treatm ent of chronic myeloid leukemia (CML) that is resistant to treatment with Gl eevec.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB39AvxVHB29HN2DVIIDXZV8HcD8tzcXD2dFRydPV0UHP1cFFxcgzzDHEM8w1yDeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvLOjkZmZkaGRmaOhMRFKAHA4JNM</recordid><startdate>20080306</startdate><enddate>20080306</enddate><creator>WAGH, VILAS SAMPATRAO</creator><creator>DESHPANDE, AMIT</creator><creator>AWARE, VALMIK SOPAN</creator><creator>SARDE, ANKUSH GANGARAM</creator><creator>SHARMA, SOMESH</creator><creator>SIVAKUMAR, MEENAKSHI</creator><creator>JOSHI, KALPANA SANJAY</creator><scope>EVB</scope></search><sort><creationdate>20080306</creationdate><title>ANTI CANCER USE OF CAFFEIC ACID AND DERIVATIVES</title><author>WAGH, VILAS SAMPATRAO ; DESHPANDE, AMIT ; AWARE, VALMIK SOPAN ; SARDE, ANKUSH GANGARAM ; SHARMA, SOMESH ; SIVAKUMAR, MEENAKSHI ; JOSHI, KALPANA SANJAY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2662126A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2008</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WAGH, VILAS SAMPATRAO</creatorcontrib><creatorcontrib>DESHPANDE, AMIT</creatorcontrib><creatorcontrib>AWARE, VALMIK SOPAN</creatorcontrib><creatorcontrib>SARDE, ANKUSH GANGARAM</creatorcontrib><creatorcontrib>SHARMA, SOMESH</creatorcontrib><creatorcontrib>SIVAKUMAR, MEENAKSHI</creatorcontrib><creatorcontrib>JOSHI, KALPANA SANJAY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WAGH, VILAS SAMPATRAO</au><au>DESHPANDE, AMIT</au><au>AWARE, VALMIK SOPAN</au><au>SARDE, ANKUSH GANGARAM</au><au>SHARMA, SOMESH</au><au>SIVAKUMAR, MEENAKSHI</au><au>JOSHI, KALPANA SANJAY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI CANCER USE OF CAFFEIC ACID AND DERIVATIVES</title><date>2008-03-06</date><risdate>2008</risdate><abstract>The present invention relates to the use of caffeic acid or a derivative thereof represented by the following general formula (1) wherein X is O, NH, or heterocyclyl; R may be present or absent and if present, is H, alkyl, ar yl, or heterocyclyl; in all its stereoisomeric and tautomeric forms, and mix tures thereof in all ratios, and a pharmaceutically acceptable salt, pharmac eutically acceptable solvate, pharmaceutically acceptable polymorph, in the treatment of chronic myeloid leukemia (CML) which is resistant to treatment with Gleevec. The invention also relates to the reduction of the proliferati on of cells that are resistant to Gleevec by contacting the cells with a com pound of general formula (1 ). The present invention also relates to pharmac eutical compositions (for the manufacture of the medicament) including caffe ic acid or a derivative or a salt thereof represented by the general formula (1 ) for the treatment of chronic myeloid leukemia (CML) that is resistant to treatment with Gleevec, or for reducing the proliferation of cells that a re resistant to Gleevec. The present invention further relates to the treatm ent of chronic myeloid leukemia (CML) that is resistant to treatment with Gl eevec.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2662126A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANTI CANCER USE OF CAFFEIC ACID AND DERIVATIVES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A52%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WAGH,%20VILAS%20SAMPATRAO&rft.date=2008-03-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2662126A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |